×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ABT – abbott laboratories (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ABT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/4
09:11 pm
abt
?????????????????????????????????????2035????38???????????????????????????(CAGR)?6.11%?????????? [CNET News]
Low
Report
?????????????????????????????????????2035????38???????????????????????????(CAGR)?6.11%?????????? [CNET News]
2/4
06:42 pm
abt
Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths [CNET News]
Low
Report
Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths [CNET News]
2/4
02:44 pm
abt
Do Wall Street Analysts Like Abbott Laboratories Stock? [Yahoo! Finance]
Low
Report
Do Wall Street Analysts Like Abbott Laboratories Stock? [Yahoo! Finance]
2/4
08:22 am
abt
AbbVie's (NYSE:ABBV) Q4 CY2025: Beats On Revenue [Yahoo! Finance]
Low
Report
AbbVie's (NYSE:ABBV) Q4 CY2025: Beats On Revenue [Yahoo! Finance]
2/4
06:46 am
abt
Medtronic set to acquire CathWorks for $585m [Yahoo! Finance]
Low
Report
Medtronic set to acquire CathWorks for $585m [Yahoo! Finance]
2/3
09:29 am
abt
Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure [Yahoo! Finance]
Low
Report
Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure [Yahoo! Finance]
2/2
10:09 pm
abt
Abbott Labs CEO makes $2M bet as stock sinks [Yahoo! Finance]
Low
Report
Abbott Labs CEO makes $2M bet as stock sinks [Yahoo! Finance]
2/2
08:55 pm
abt
Abbott Laboratories (ABT): A Bull Case Theory [Yahoo! Finance]
Low
Report
Abbott Laboratories (ABT): A Bull Case Theory [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/26
08:02 am
abt
Form 4 ABBOTT LABORATORIES For: Jan 23 Filed by: Ford Robert B
Low
Report
Form 4 ABBOTT LABORATORIES For: Jan 23 Filed by: Ford Robert B
1/22
07:35 am
abt
Form 8-K ABBOTT LABORATORIES For: Jan 22
Medium
Report
Form 8-K ABBOTT LABORATORIES For: Jan 22
1/5
06:47 pm
abt
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Stratton John G
Low
Report
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Stratton John G
1/5
06:26 pm
abt
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Roman Michael F
Low
Report
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Roman Michael F
1/5
06:16 pm
abt
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Gonzalez Patricia Paola
Low
Report
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Gonzalez Patricia Paola
1/5
06:01 pm
abt
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Alpern Robert J
Low
Report
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Alpern Robert J
12/23
07:31 pm
abt
Form 3 ABBOTT LABORATORIES For: Dec 12 Filed by: Ahuja Nita
Low
Report
Form 3 ABBOTT LABORATORIES For: Dec 12 Filed by: Ahuja Nita
12/19
04:40 pm
abt
Form 3 ABBOTT LABORATORIES For: Dec 12 Filed by: Scoggins Christopher J
Low
Report
Form 3 ABBOTT LABORATORIES For: Dec 12 Filed by: Scoggins Christopher J
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Abbott Labs Is Sliding Closer To Attractive Territory [Seeking Alpha]
10.0%
3/16 Form 4 ABBOTT LABORATORIES For: Mar 13 Filed by: Boudreau Philip P 6.6%
3/27 Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes 6.4%
4/16 Form 8-K ABBOTT LABORATORIES For: Apr 16 5.6%
3/1 The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool] 5.4%
3/3 Form 4 ABBOTT LABORATORIES For: Feb 28 Filed by: Wainer Andrea F 5.2%
3/9 Form 3 ABBOTT LABORATORIES For: Mar 01 Filed by: Boudreau Philip P 5.0%
4/8 Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic 4.7%
4/13 Fed Circuit orders new trial in Abbott drug test patent case [Reuters] 4.2%
4/3 UPDATE 2-Anyone near Trump or Pence will be given rapid coronavirus test - White House [Reuters] 4.1%
3/16 Form 4 ABBOTT LABORATORIES For: Mar 13 Filed by: Boudreau Philip P 6.6%
3/27 Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes 6.4%
4/16 Form 8-K ABBOTT LABORATORIES For: Apr 16 5.6%
3/1 The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool] 5.4%
3/3 Form 4 ABBOTT LABORATORIES For: Feb 28 Filed by: Wainer Andrea F 5.2%
3/9 Form 3 ABBOTT LABORATORIES For: Mar 01 Filed by: Boudreau Philip P 5.0%
4/8 Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic 4.7%
4/13 Fed Circuit orders new trial in Abbott drug test patent case [Reuters] 4.2%
4/3 UPDATE 2-Anyone near Trump or Pence will be given rapid coronavirus test - White House [Reuters] 4.1%
TOP News Decliners
3/18
Associated Press: Cancer and heart surgeries now delayed as coronavirus alters care [MarketWatch]
-10.8%
3/13 Form DEF 14A ABBOTT LABORATORIES For: Apr 24 -10.6%
3/22 You Won't Regret Buying These 3 Bargain Stocks [The Motley Fool] -9.8%
3/19 Africa coronavirus cases to rise as some undetected - Africa's CDC [Reuters] -8.7%
2/3 Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke -5.4%
2/25 The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes] -4.4%
3/27 Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Morgan Stanley from $101.00 to $96.00. They now have an "overweight" rating on the stock. -3.7%
3/31 Phase 4 Coronavirus Infrastructure Spending To Start At $2 Trillion [Forbes] -3.7%
8/13 Form 4 ABBOTT LABORATORIES For: Aug 09 Filed by: Funck Robert E -3.5%
3/10 Form 4 ABBOTT LABORATORIES For: Mar 06 Filed by: Watkin Jared -3.4%
3/13 Form DEF 14A ABBOTT LABORATORIES For: Apr 24 -10.6%
3/22 You Won't Regret Buying These 3 Bargain Stocks [The Motley Fool] -9.8%
3/19 Africa coronavirus cases to rise as some undetected - Africa's CDC [Reuters] -8.7%
2/3 Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke -5.4%
2/25 The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes] -4.4%
3/27 Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Morgan Stanley from $101.00 to $96.00. They now have an "overweight" rating on the stock. -3.7%
3/31 Phase 4 Coronavirus Infrastructure Spending To Start At $2 Trillion [Forbes] -3.7%
8/13 Form 4 ABBOTT LABORATORIES For: Aug 09 Filed by: Funck Robert E -3.5%
3/10 Form 4 ABBOTT LABORATORIES For: Mar 06 Filed by: Watkin Jared -3.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: